Can a practice use an AI scribe in the exam room?

Start with the recording, because it is the part governed by a body of law that has nothing to do with healthcare. Whether a conversation may be recorded is set by state wiretapping and eavesdropping statutes, and the states divide between those requiring one party's consent and those requiring everyone's. A clinician consents by operating the device; the patient does not, and in an all-party state that gap is the whole exposure. It is also easily closed — the consent is asked for and recorded before the session — which is why practices that missed it usually missed it by never asking the question rather than by answering it wrongly.

Illinois adds a second, separate problem that catches practices by surprise, and it is not about the recording. Its biometric statute treats a voiceprint as a biometric identifier, and analysis of vocal characteristics to distinguish or identify a speaker is what several transcription products do in order to separate the clinician from the patient. That triggers a written release requirement and a private right of action, and the exposure attaches to the analysis rather than to the audio. A practice with Illinois patients should establish what the product does with voice specifically, not merely that it transcribes.

The vendor relationship is the ordinary business associate analysis, with one wrinkle that matters here more than elsewhere. Ambient products capture everything said in the room, including things the patient said that the clinician would not have written down and things a family member said about themselves. The retention terms therefore govern a richer record than the note does, and the question of how long the audio survives after the note is signed is worth asking explicitly rather than assuming it mirrors the record retention policy.

The clinical question is the one that eventually decides whether this works, and it is about attestation rather than accuracy. A signed note is the clinician's representation that the record reflects the encounter. A generated draft is a proposal about what happened, and it can be fluent, plausible and wrong in exactly the way that reads as competent documentation: a symptom that was mentioned as absent recorded as present, a plan the clinician considered and rejected recorded as the plan, a history assembled from context rather than from what was said.

Which means the review has to be targeted at the parts that are cheap to get wrong and expensive to miss. Negatives, medications, allergies, the assessment and the plan carry consequences; the narrative of the presenting complaint mostly does not. A clinician reading the whole note evenly will spend the time and catch less than one reading those five things first. That is a small change in habit and it is the difference between review and a countersignature.

Finally, the note is downstream of more than the patient. It supports the coding, the claim, and any later audit of both, and a note that overstates what was documented is a billing exposure with a different regulator attached. Practices that adopted ambient documentation and saw their coding levels move should treat the movement as a question rather than as a benefit, because a defensible level requires the documentation to have actually happened.